PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Lidocaine - Post herpetic neuralgia
PAD Profile : Lidocaine - Post herpetic neuralgia Important
Keywords :
PHN, lidocaine patch, lignocaine patch, lidocaine plaster, postherpetic neuralgia, post-herpetic neuralgia
Brand Names Include :
Versatis, Ralvo
Important Information :
Post herpetic neuralgia only.
Acute Trusts are restricted to Pain Team initiation only
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
No drugs returned.
Other Indications
No indications returned.
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
07 October 2020
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
Lidocaine 5% plasters are only recommended in local neuropathic pain guidelines for post-herpetic neuralgia with localised allodynia.
Lidocaine plasters are recommended at step 3 of the local neuropathic pain guidelines but may be considered 1st line where:
- the painful area is less than 5cm2
- the patient is unable to take oral medication
- there is a risk of drug-drug interaction with treatments in steps 2 and 3
- there is an increased risk of falls
see guidelines below for further information
Associated BNF Codes
04. Central Nervous System
04.07.03. Neuropathic pain